Recurrent Thyroid Cancer Completed Phase 2 Trials for Vorinostat (DB02546)

Also known as: Thyroid cancer recurrent

IndicationStatusPhase
DBCOND0028815 (Recurrent Thyroid Cancer)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00134043Suberoylanilide Hydroxamic Acid in Treating Patients With Metastatic and/or Locally Advanced or Locally Recurrent Thyroid CancerTreatment